Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Anti-Cancer Drugs|January 8, 2014
Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancerEdoardo Francini, Anna Ida Fiaschi, Roberto Petrioli, et al.
Critical Reviews in Oncology/Hematology|April 17, 2016
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysisRoberto Petrioli, Giandomenico Roviello, Laura Zanotti, et al.
Cancer Investigation|January 13, 2012
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumabRoberto Petrioli, Antonella Licchetta, Giandomenico Roviello, et al.
Clinical Lung Cancer|June 15, 2015
Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution ExperienceRoberto Petrioli, Giandomenico Roviello, Letizia Laera, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2007
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatinRoberto Petrioli, Alessandra Pascucci, Edoardo Francini, et al.
Clinical Colorectal Cancer|August 30, 2018
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal CancerRoberto Petrioli, Edoardo Francini, Sara Cherri, et al.
Oncology|May 22, 2003
Weekly low-dose docetaxel in advanced hormone-resistant prostate cancer patients previously exposed to chemotherapyRoberto Petrioli, Daniele Pozzessere, Simona Messinese, et al.
Journal of Surgical Oncology|August 20, 2010
Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancerFranco Roviello, Enrico Pinto, Giovanni Corso, et al.
Cancers|December 23, 2022
Immunohistochemical Markers of the Epithelial-to-Mesenchymal Transition (EMT) Are Related to Extensive Lymph Nodal Spread, Peritoneal Dissemination, and Poor Prognosis in the Microsatellite-Stable Diffuse Histotype of Gastric CancerDaniele Marrelli, Luigi Marano, Maria Raffaella Ambrosio, et al.
Journal of Geriatric Oncology|August 1, 2015
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance statusRoberto Petrioli, Edoardo Francini, Franco Roviello, et al.
Pageof 11